Additionally, FSH and its receptors have been reported to have an association with metabolic health [40] and have been implicated in the induction of metabolic diseases through multiple pathways including adipose accumulation, and contribute to obesity, diabetes, and non-alcoholic fatty liver disease [41]. This evidence concerns the gene BRD2 and metabolic dysfunction-associated steatotic liver disease.